APA

Llombart-Cussac A., Martin M., Harbeck N., Anghel R. M., Eniu A. E., Verrill M. W., Neven P., De Grève J., Melemed A. S., Clark R., Simms L., Kaiser C. J. & Ma D. (20071004). A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Llombart-Cussac Antonio, Martin Miguel, Harbeck Nadia, Anghel Rodica M, Eniu Alexandra E, Verrill Mark W, Neven Patrick, De Grève Jacques, Melemed Allen S, Clark Romnee, Simms Lorinda, Kaiser Christopher J and Ma Doreen. 20071004. A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Llombart-Cussac A., Martin M., Harbeck N., Anghel R. M., Eniu A. E., Verrill M. W., Neven P., De Grève J., Melemed A. S., Clark R., Simms L., Kaiser C. J. and Ma D. (20071004). A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Llombart-Cussac Antonio, Martin Miguel, Harbeck Nadia, Anghel Rodica M, Eniu Alexandra E, Verrill Mark W, Neven Patrick, De Grève Jacques, Melemed Allen S, Clark Romnee, Simms Lorinda, Kaiser Christopher J and Ma Doreen. A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20071004.